diazene has been researched along with Cancer of Larynx in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bordukalo, T; Jernej, B; Kosmrlj, J; Osmak, M; Polanc, S | 1 |
Bordukalo, T; Eljuga, D; Kosmrlj, J; Kvajo, M; Marijanović, Z; Osmak, M; Polanc, S | 1 |
2 other study(ies) available for diazene and Cancer of Larynx
Article | Year |
---|---|
Diazene JK-279: potential anticancer drug.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Glioblastoma; Humans; Imides; Laryngeal Neoplasms; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1999 |
Diazenes: modificators of tumor cell resistance to cisplatin.
Topics: Antineoplastic Agents; Cell Survival; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione; HeLa Cells; Humans; Imides; Indicators and Reagents; Kinetics; Laryngeal Neoplasms; Tumor Cells, Cultured | 1999 |